cholesterol

Biotech

FDA hands Verve list of demands for lifting gene editing hold

Officials want additional data to allay concerns that patients could pass on the edited genes to their children before they lift the clinical hold.
Nick Paul Taylor Dec 5, 2022 9:20am

Verily's Onduo slashes blood sugar in Type 2 diabetes patients

Nov 7, 2022 10:30am

Merck looks to cardiovascular pipeline for $10B-plus peak sales

Apr 5, 2022 5:24pm

ACC: Ionis-AstraZeneca drug reduces troublesome cholesterol

Apr 4, 2022 10:08am

Phase 3 hits tee Innovent up to rival Amgen and Sanofi in PCSK9

Feb 17, 2022 9:40am

AstraZeneca punts midphase cardiovascular prospect to startup

Feb 3, 2022 7:05am